M-Teriflunomide
30 tablets of 14 mg (blister pack)
– DIN 02523833
-
Canadian Reference Product
Aubagio®
-
Medicinal Ingredient
Teriflunomide
-
DIN
02523833
-
Strength
14 mg
-
Pack Size
30 tablets
-
Patient Support Program
Visit the MantrAssistance website
Information for Patients
- Patient Medication Information
- Patient Information Brochure
- Educational Patient Card
-
Pregnancy Active Surveillance Program
+1-833-651-1661
Information for Healthcare Professionals
- Product Monograph
- Prescriber’s Checklist
-
Targeted questionnaires
- Hepatic effects targeted questionnaire AE follow-up form
- Hypertension targeted questionnaire AE follow-up form
- Hematologic effects targeted questionnaire AE follow-up form
- Infections targeted questionnaire AE follow-up form
- Pancreatic effects targeted questionnaire AE follow up form
- Peripheral neuropathy targeted questionnaire AE follow-up form
- Progressive Multifocal Leukoencephalopathy (PML) AE follow-up form
- Interstitial lung disease targeted questionnaire AE follow-up form
- Infant follow-up form
- Teriflunomide Exposure in Pregnancy form
-
Pregnancy Active Surveillance Program
+1-833-651-1661
Assistance
-
Medical Information
+1-833-248-7326